Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Seroprevalence of Mumps Before Inclusion of Mumps Vaccination in the Iranian Expanded Programme on Immunization Publisher Pubmed



Avijgan M1, 2 ; Habibian R2 ; Kheiri S3
Authors

Source: Eastern Mediterranean Health Journal Published:2009


Abstract

The current target groups for measles, mumps and rubella vaccination in the Islamic Republic of Iran are children at 12 months and 4-6 years. A study of the age-specific seroprevalence of antibodies against mumps in children aged 3-18 years in Shahrekord aimed to establish the need for booster vaccinations to cover non-immune children. Of 338 children, 19.8% were seronegative. Age-specific seronegativity was 33.3%, 20.5% and 4.6% in age groups 7-11, 12-14 and 15-18 years respectively. To obtain herd immunity, we suggest that for the next 5 years children aged 7-11 years entering guidance school are selected as the main group for vaccination.
Other Related Docs
4. Survival Analysis for Predictive Factors of Delay Vaccination in Iranian Children, International Journal of Preventive Medicine (2015)
6. Should We Consider Another Booster Dose of Measles Vaccine?, Iranian Journal of Medical Sciences (2002)